Kadmon will form a life sciences venture with Nano Terra

04/25/2011 | Xconomy · Genetic Engineering & Biotechnology News

Nano Terra and Kadmon Pharmaceuticals intend to create a joint venture, NT Life Sciences, to work on the former's Pharmacomer drug-discovery platform and three of its enzyme-targeting compounds. Kadmon will have exclusive global rights to the investigational drugs and the technology.

View Full Article in:

Xconomy · Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN